Evidence map›Paper›PMID 40896390›Full record

ArticleIDCases2025

Immune mediated hemolysis after Chikungunya viral infection.

Daniel Y Reuben, Eugene H Lewis

Abstract readCase Reports
In one paragraph

Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daniel Y ReubenCancer Institute - Fairfield, Hartford HealthCare, St. Vincent's Medical Center, Bridgeport, CT, United States.
Eugene H LewisFrank H. Netter School of Medicine, Quinnipiac University, North Haven, CT, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case describes a patient with recent Chikungunya viral infection and developing anemia after international travel to an endemic region. This viral exposure has become more common and occasionally seen in North America. Pertinent findings of the case are described. Post-viral hemolytic anemia was found 9 weeks after exposure in this patient. The patient's anemia persisted for 15 weeks until a full recovery of hemoglobin levels and hemolysis labs occurred. The patient was able to be followed expectantly. Post-viral symptom management generally employs supportive measures for symptomatic patients. Decisions regarding the evaluation and management of the anemia are described. Immune-mediated hemolysis has not been consistently reported in association with prior Chikungunya infection to date. As the incidence of Chikungunya infections has escalated in the last few decades it will be important for clinicians to understand this related post-viral hematologic occurrence with possible comorbidity.

Indexed as

AnemiaChikungunyaHemolyticImmuneViral

Identifiers

PMID40896390
PMCPMC12392649

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.